Patent · US Active

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation

US12209238B2 · kind B2 · utility

1Cited by
6References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2023
Grant dateJan 28, 2025
Priority date
Expiry dateNov 6, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7047
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Cas-protein-ready tau biosensor cells, CRISPR/Cas synergistic activation mediator (SAM)-ready tau biosensor cells, and methods of making and using such cells to screen for genetic modifiers of tau seeding or aggregation are provided. Reagents and methods for sensitizing such cells to tau seeding activity or tau aggregation or for causing tau aggregation are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.